BRAFV600E mutant, PD-L1 TPS 90% NSCLC: 1st line treatment with targeted therapy
@article{PCM5969, author = {Edwin H. Yau}, title = {BRAFV600E mutant, PD-L1 TPS 90% NSCLC: 1st line treatment with targeted therapy}, journal = {Precision Cancer Medicine}, volume = {4}, number = {0}, year = {2021}, keywords = {}, abstract = {}, issn = {2617-2216}, url = {https://pcm.amegroups.org/article/view/5969} }